Bone Care International Announces Fourth Quarter Earnings Release Conference Call.Business Editors/Health & Medical Writers MIDDLETON, Wis.--(BUSINESS WIRE)--July 24, 2002 Bone Care International, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BCII BCII Battle Command and Intelligence Integration ) has scheduled its fourth quarter earnings release conference call for August 6, 2002, at 10:00 a.m. central time. The toll-free number within North America is 888-881-4892; the dial-in number for international participants is 416-640-4127. The call is available for playback until August 8 at 877-289-8525 within North America and at 416-640-1917 for international callers. The playback pass code is 195231. The presentation will also be available at Bone Care's web site, www.bonecare.com. Bone Care is a pharmaceutical company engaged in discovering, developing and commercializing improved vitamin D-hormone therapies to treat secondary hyperparathyroidism secondary hyperparathyroidism Endocrinology ↑ Parathyroid activity with overproduction of PTH due to parathyroid hyperplasia in response to an extraparathyroid defect that results in ↓ Ca2+ Etiology Rickets, vitamin D deficiency, chronic renal failure in patients with kidney, or renal disease Renal disease Kidney disease. Mentioned in: Glycogen Storage Diseases hypertension High blood pressure Cardiovascular disease An abnormal ↑ systemic arterial pressure, corresponding to a systolic BP of > 160 mm Hg , and osteoporosis, and other diseases including psoriasis and cancers of the prostate, breast and colon. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion